News
News releases on January 12, 2026, page 18
Every news release public companies put out on January 12, 2026 (UTC): 1,920 news releases, newest first. Open any release to read it.
Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44t...
Precigen, Inc. · Jan 12, 2026
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress
Praxis Precision Medicines, Inc. · Jan 12, 2026
Petco Announces Launch of Debt Refinancing Transaction; Reaffirms Fourth Quarter and Full Fiscal Year 2025 Outlook
Petco Health and Wellness Company, Inc. · Jan 12, 2026
Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™
Personalis, Inc. · Jan 12, 2026
PensionBee Launches on SS&C’s RolloverCentral®, Offering 1% Match on All Rollovers and Contributions
SS&C Technologies Holdings, Inc. · Jan 12, 2026
Palantir Announces Date of Fourth Quarter 2025 Earnings Release and Webcast
Palantir Technologies Inc. · Jan 12, 2026
Pagaya to Participate in Upcoming Investor Conferences and Events
Pagaya Technologies Ltd. · Jan 12, 2026
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
Pacific Biosciences of California, Inc. · Jan 12, 2026
Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001
Oruka Therapeutics, Inc. · Jan 12, 2026
OneSpaWorld Announces Preliminary Fourth Quarter and Fiscal Year 2025 Revenue and Adjusted EBITDA and Introduces Fiscal 2026 Revenue and ...
OneSpaWorld Holdings Limited · Jan 12, 2026
Omada Health Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2025
Omada Health, Inc. · Jan 12, 2026
NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
NVIDIA Corporation · Jan 12, 2026
NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI
NVIDIA Corporation · Jan 12, 2026
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Ca...
Nurix Therapeutics, Inc. · Jan 12, 2026
Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
NovoCure Limited · Jan 12, 2026
Northwestern Medicine Selects Tempus to Expand Genomic Testing
Tempus AI, Inc. · Jan 12, 2026
NorthWestern Energy to Host Year-End 2025 Financial Results Webinar
NorthWestern Energy Group, Inc. · Jan 12, 2026
Northern Lights Resources Advances Corporate Governance with Appointment of Lisa Thompson as Director
Northern Lights Resources Corp · Jan 12, 2026
NioCorp Reports Final Assay Results From the Department of War-Funded Elk Creek Drilling Campaign
NioCorp Developments Ltd. · Jan 12, 2026
NioCorp Provides Preliminary Unaudited Financial Results for the Three- and Six-Month Periods Ended December 31, 2025
NioCorp Developments Ltd. · Jan 12, 2026
NGEx Minerals Drills 94.00m at 8.99% CuEq including 21.70m 31.92% CuEq at Lunahuasi
NGEx Minerals Ltd. · Jan 12, 2026
Newmark Arranges 1.4 Million-Square-Foot Industrial Lease with Leading Beverage Manufacturer DrinkPAK
Newmark Group, Inc. · Jan 12, 2026
NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived ...
NewcelX Ltd. · Jan 12, 2026
Netcapital to Tokenize Hydrogen Drilling Assets
Netcapital Inc. · Jan 12, 2026
Navan Accelerates NDC Adoption with New Emirates Partnership
Navan, Inc. · Jan 12, 2026
Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA
Natera, Inc. · Jan 12, 2026
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Moderna, Inc. · Jan 12, 2026
Mobileye Announces Timing of its Fourth Quarter and Full Year 2025 Results
Mobileye Global Inc. · Jan 12, 2026
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. · Jan 12, 2026
Medallion Bank Announces Executive Promotions
Medallion Financial Corp. · Jan 12, 2026
Masimo Announces Select Preliminary 2025 Financial Results
Masimo Corporation · Jan 12, 2026
Lundin Gold Achieves Record Q4 Throughput and Achieves 2025 Production Guidance with 498,315 Ounces of Gold
Lundin Gold Inc. · Jan 12, 2026
LPL Financial Appoints Ilan Davidovici as Executive Vice President, Corporate Strategy
LPL Financial Holdings Inc. · Jan 12, 2026
Limbach to Participate in CJS Annual New Ideas for the New Year Conference
Limbach Holdings, Inc. · Jan 12, 2026
Leonardo DRS Schedules Fourth Quarter 2025 and Full Year 2025 Earnings Conference Call for February 24, 2026
Leonardo DRS, Inc. · Jan 12, 2026
Kyivstar Launches 5G Pilot Program in Lviv
Kyivstar Group Ltd. · Jan 12, 2026
Kustom Entertainment, Inc. completes the divestiture of its Nobility Healthcare subsidiary; sharpens its focus on $100 billion live Enter...
Kustom Entertainment, Inc. · Jan 12, 2026
Kratos Continues U.S. Defense Industrial Base Build Out with Expansion of Birmingham Operations with New 40,000-Square-Foot Facility
Kratos Defense & Security Solutions, Inc. · Jan 12, 2026
Jack Henry Rapid Transfers Delivers Competitive Edge to Banks and Credit Unions
Jack Henry & Associates, Inc. · Jan 12, 2026
Ionis well-positioned for continued momentum and substantial value creation in 2026 with two new independent launches and several pivotal...
Ionis Pharmaceuticals, Inc. · Jan 12, 2026
Hudbay Minerals Announces Closing of $600 Million Strategic Investment from Mitsubishi for 30% Joint Venture Interest in Copper World
Hudbay Minerals Inc · Jan 12, 2026
Henry Schein Names Frederick M. Lowery as Chief Executive Officer
Henry Schein, Inc. · Jan 12, 2026
Grocery Outlet Enters Sixteenth State with Store Opening in Virginia
Grocery Outlet Holding Corp. · Jan 12, 2026
Green Plains Expands Leadership Team with Ryan Loneman as General Counsel
Green Plains, Inc. · Jan 12, 2026
Geron Corporation Provides 2026 Financial Guidance
Geron Corporation · Jan 12, 2026
Gaming and Leisure Properties, Inc. Schedules Fourth Quarter 2025 Earnings Release and Conference Call
Gaming and Leisure Properties, Inc. · Jan 12, 2026
Five Below, Inc. Announces Holiday Sales Results for Quarter-To-Date Through January 3, 2026
Five Below, Inc. · Jan 12, 2026
First Watch Restaurant Group, Inc. Reports Preliminary Operational Metrics for the Fourth Quarter and Fiscal Year 2025
First Watch Restaurant Group, Inc. · Jan 12, 2026
First Abu Dhabi Bank and T. Rowe Price Enter into a Strategic Partnership to Enhance Investment Offering across the GCC
T. Rowe Price Group, Inc. · Jan 12, 2026
Figure Technology Solutions Reports Preliminary Q4 2025 & December Operating Data
Figure Technology Solutions, Inc. · Jan 12, 2026
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025
Establishment Labs Holdings Inc. · Jan 12, 2026
Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones
Erasca, Inc. · Jan 12, 2026
Enphase Energy Begins Shipments of IQ9 Commercial Microinverters in the United States
Enphase Energy, Inc. · Jan 12, 2026
Energy Leaders Abunayyan Holding and Nextpower Complete Formation of Joint Venture, Nextpower Arabia
Flex Ltd. · Jan 12, 2026
Duolingo Announces CFO Transition
Duolingo, Inc. · Jan 12, 2026
Digi International Introduces Digi Ventus™ Managed Connectivity Solutions
Digi International Inc. · Jan 12, 2026
Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization
Dentsply Sirona Inc. · Jan 12, 2026
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, S...
Datavault AI Inc. · Jan 12, 2026
CrowdStrike and Nord Security Announce Strategic Partnership to Redefine SMB Cybersecurity
CrowdStrike Holdings, Inc. · Jan 12, 2026
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026
Connect Biopharma Holdings Limited · Jan 12, 2026
ComEd Offering $515,000 in Grants to Support Community Programs Across Northern Illinois
Exelon Corporation · Jan 12, 2026
Cogent Biosciences Announces Anticipated 2026 Commercial and Clinical Milestones for Bezuclastinib and Precision Therapies Portfolio
Cogent Biosciences, Inc. · Jan 12, 2026
Coastal Bend LNG Selects KBR and Técnicas Reunidas for FEED and EPC
ConocoPhillips · Jan 12, 2026
CitiTrends Announces 2025 Holiday Sales Results
Citi Trends, Inc. · Jan 12, 2026
Churchill Downs Incorporated Announces Development Plans for Casino in Salem, New Hampshire
Churchill Downs, Incorporated · Jan 12, 2026
Caris Life Sciences Partners with Everlywell to Launch Caris' Forthcoming MCED Assay, Caris Detect
Caris Life Sciences, Inc. · Jan 12, 2026
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
Caris Life Sciences, Inc. · Jan 12, 2026
Bitdeer Announces December 2025 Production and Operations Update
Bitdeer Technologies Group · Jan 12, 2026
BioCryst Announces Preliminary Full Year 2025 ORLADEYO® (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Gui...
BioCryst Pharmaceuticals, Inc. · Jan 12, 2026
Bicara Therapeutics Announces Phase 3 Optimal Dose and Provides 2026 Corporate Outlook
Bicara Therapeutics Inc. · Jan 12, 2026
BGC Group to Report Fourth Quarter 2025 Financial Results on February 12, 2026
BGC Group, Inc. · Jan 12, 2026
BCP Investment Corporation Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
BCP Investment Corporation · Jan 12, 2026
Barbie® Introduces the First Autistic Barbie Doll, Championing Representation for Children through Play
Asana, Inc. · Jan 12, 2026
Barbie® Introduces the First Autistic Barbie Doll, Championing Representation for Children through Play
Mattel, Inc. · Jan 12, 2026
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue
Axsome Therapeutics, Inc. · Jan 12, 2026
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
Axogen, Inc. · Jan 12, 2026
Axe Compute (NASDAQ: AGPU) Named Sponsor of the Sequire Investor Summit Puerto Rico 2026
Axe Compute Inc. · Jan 12, 2026
Avventura Resources Expands Land Position At Horwood Through Amended Option Agreement
Avventura Resources Ltd. · Jan 12, 2026
Aura Announces Preliminary Q4 2025 and 2025 Production Results; Record High Production and 2025 Guidance Achieved
Aura Minerals Inc. · Jan 12, 2026
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026
AtriCure, Inc. · Jan 12, 2026
Arcutis Highlights 2026 Strategic Priorities and Anticipated Milestones
Arcutis Biotherapeutics, Inc. · Jan 12, 2026
Apellis Highlights Commercial Execution and Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference
Apellis Pharmaceuticals, Inc. · Jan 12, 2026
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthet...
Amphastar Pharmaceuticals, Inc. · Jan 12, 2026
Alliant Energy Corporation Declares Quarterly Common Stock Dividend
Alliant Energy Corporation · Jan 12, 2026
Akebia Therapeutics Announces Corporate Updates and 2026 Pipeline Outlook
Akebia Therapeutics, Inc. · Jan 12, 2026
AIxCrypto Launches AIxC Hub Ecosystem Platform; Inaugural S1 Arena Attracts Over 200,000 Participants in Five Days
AIxCrypto Holdings, Inc. · Jan 12, 2026
AGM Holdings Signs Strategic Memorandum of Understanding to Enter the New Arena of Real-World Asset (RWA) Tokenization
AGM Group Holdings Inc. · Jan 12, 2026
Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth
Agios Pharmaceuticals, Inc. · Jan 12, 2026
ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update
ADMA Biologics Inc · Jan 12, 2026
Actuate Therapeutics Reports Positive Follow-Up Data from its Randomized Controlled Phase 2 Trial Demonstrating Extended Long-Term Overal...
Actuate Therapeutics, Inc. · Jan 12, 2026
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Atopic Dermatitis (AD) with Its Novel Bispecific Antibody ATI-052
Aclaris Therapeutics, Inc. · Jan 12, 2026
ACI Worldwide Adds Paze ℠ Online Checkout from Early Warning Services to Pay.On Platform, Expanding Wallet Options for U.S. Consumers
ACI Worldwide, Inc. · Jan 12, 2026
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Sym...
AbCellera Biologics Inc. · Jan 12, 2026
3 E Network Announces the Signing of Land Lease Agreement with City of Mikkeli, Finland
3 E Network Technology Group Ltd · Jan 12, 2026
Explanation on Request for Explanation of the Exchange
PT Mahaka Radio Integra Tbk · Jan 12, 2026
Royal Orchid Hotels Limited Press Release Jan 12 2026
Royal Orchid Hotels Limited · Jan 12, 2026
Maris Spinners Ltd. Press Release Jan 12 2026
Maris Spinners Ltd. · Jan 12, 2026
Compliances-Reg. 90 (1) Declaration of NAV - Mutual Fund
UTI BSE Sensex ETF · Jan 12, 2026
K3i Co Ltd Wins 912 Million Won Order
K3I Co., Ltd. · Jan 12, 2026
ESG Says Royal Development Holding Signs Agreements With Rotana Hotels & Resorts Group
Esg Emirates Stallions Group P.J.S.C · Jan 12, 2026